{"id":"5da84366-cafb-5ecc-ba2a-71270b48227f","stable_key":"33bef151-bdc7-5892-aff6-0345ab149739:a-hemorrhage-followed-combined-nattokinase-and-aspirin-use","predicate":"increases","statement":"A patient taking aspirin for secondary stroke prevention had an acute cerebellar hemorrhage after seven consecutive days of nattokinase at 400 mg daily, with multiple cerebral microbleeds on MRI.","claim_class":"mechanistic","status":"source_derived_draft","evidence_grade":"ungraded","direction":"positive","is_public":true,"mechanism_event_id":"c588c90c-a5a3-594b-9d44-80699ed0c6bb","mechanism_event_label":"A patient taking aspirin for secondary stroke prevention had an acute cerebellar hemorrhage after seven consecutive days of nattokinase at 400 mg daily, with multiple cerebral microbleeds on MRI.","subject":{"id":"e8eb9bb4-3c6f-5e96-a968-a6d1fece71e7","slug":"nattokinase-supplement","display_name":"Commercial nattokinase supplement, composition study-specific","entity_type_key":"chemical_species"},"object":{"id":"a9ad8448-7d2a-5b9d-9764-55fccdb05bb5","slug":"hemorrhage","display_name":"Hemorrhage","entity_type_key":"cellular_process"},"evidence_count":1,"mechanism_event":{"id":"c588c90c-a5a3-594b-9d44-80699ed0c6bb","stable_key":"33bef151-bdc7-5892-aff6-0345ab149739:a-hemorrhage-followed-combined-nattokinase-and-aspirin-use-event","event_type":"observed_intervention","label":"A patient taking aspirin for secondary stroke prevention had an acute cerebellar hemorrhage after seven consecutive days of nattokinase at 400 mg daily, with multiple cerebral microbleeds on MRI.","description":"Cerebellum, with cerebral microbleeds on MR imaging","status":"provisional","compartment":null,"participants":[{"entity":{"id":"e8eb9bb4-3c6f-5e96-a968-a6d1fece71e7","slug":"nattokinase-supplement","display_name":"Commercial nattokinase supplement, composition study-specific","entity_type_key":"chemical_species"},"role":"acting component","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"a9ad8448-7d2a-5b9d-9764-55fccdb05bb5","slug":"hemorrhage","display_name":"Hemorrhage","entity_type_key":"cellular_process"},"role":"component the finding is about","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""}]},"contexts":[{"dimension":"duration","value_text":"7 days","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"evidence_access","value_text":"Primary PubMed abstract and indexed metadata reviewed. Full-text method details not stated here remain unresolved.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Human (single case report)","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"Nattokinase 400 mg daily with concurrent aspirin","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"One case with strong predispositions, so neither causality nor incidence can be inferred from it. It is recorded because formal pharmacokinetic and pharmacodynamic interaction studies with warfarin, direct oral anticoagulants, aspirin or clopidogrel are absent from everything read here, and because the human aPTT and closure-time findings make an additive effect plausible.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"organism","value_text":"Human (single case report)","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"A patient taking aspirin for secondary stroke prevention had an acute cerebellar hemorrhage after seven consecutive days of nattokinase at 400 mg daily, with multiple cerebral microbleeds on MRI.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"Cerebellar hemorrhage provoked by combined use of nattokinase and aspirin in a patient with cerebral microbleeds. (2008) https://pubmed.ncbi.nlm.nih.gov/18310985/ DOI: 10.2169/internalmedicine.47.0620","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"route","value_text":"In vivo, oral","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue","value_text":"Cerebellum, with cerebral microbleeds on MR imaging","comparator":null,"unit":null,"notes":"","entity":null}],"evidence":[{"id":"bcb2f354-bff7-50dd-8d5f-08a0c6a90d05","evidence_kind":"source_excerpt","locator":"Lines 1390-1390","start_line":1390,"end_line":1390,"excerpt":"A patient taking aspirin for secondary stroke prevention had an acute cerebellar hemorrhage after seven consecutive days of nattokinase at 400 mg daily, with multiple cerebral microbleeds on MRI.","model_system":"Human (single case report)","directness":"reported_statement","verification_status":"source_derived_draft","notes":"","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"41cb127c-1c23-53aa-b7d0-5ec7f6fa3c99","stable_key":"import-33bef151-bdc7-5892-aff6-0345ab149739","title":"Nattokinase: what the purified enzyme cleaves, what survives being eaten, and the gap between the two (2026-09-23)","document_type":"imported_text","citation_label":"Original AI-assisted curation built from a supplied entity-first document of 105 entities and 129 claims. Every reference in that document was resolved against live PubMed with its abstract read and its DOI cross-checked on 2026-09-23, and the EFSA novel-food opinion was retrieved and read in full. That check corrected two PMIDs that pointed at unrelated papers, two DOIs, and two papers recorded as carrying no erratum that do carry one; it also reversed three findings the supplied document had stated backwards. Two papers carry a published correction, recorded as such and not as a retraction. Three sources are not indexed in PubMed and are cited by what they have. Laboratory lineages are recorded, so the four papers from one group, the three from another and the two readings of a single applicant dossier cannot be counted as separate lines of support. Study-specific doses, units, populations and limitations retained; activity units are never converted between systems. Not publisher full text.","file_path":"","sha256":"34fc46e0e849d06bfa13cb099a79b50679dd6fd0de8a5a0575326afdde3259c1","revision_id":"efd063e6-e982-5f6e-a4b8-6f2ffe4185ce","review_status":"unverified_draft","notes":""}}],"relations":[{"id":"f88d34fe-e243-5f38-b312-aaf35b066cf6","relation_type":"limits_scope_of","notes":"Low intrinsic toxicity in an animal battery does not address an interaction with an antiplatelet drug in a person with fragile cerebral vessels.","source_claim_id":"b212da43-0928-51ef-8af2-21d23cb51cae","source_claim_key":"33bef151-bdc7-5892-aff6-0345ab149739:the-subchronic-rat-noael-is-the-highest-dose-tested","source_statement":"In a 90-day oral study in Sprague-Dawley rats at 0, 100, 300 and 1,000 mg/kg body weight per day, the no-observed-adverse-effect level was 1,000 mg/kg per day, the highest dose tested.","target_claim_id":"5da84366-cafb-5ecc-ba2a-71270b48227f","target_claim_key":"33bef151-bdc7-5892-aff6-0345ab149739:a-hemorrhage-followed-combined-nattokinase-and-aspirin-use","target_statement":"A patient taking aspirin for secondary stroke prevention had an acute cerebellar hemorrhage after seven consecutive days of nattokinase at 400 mg daily, with multiple cerebral microbleeds on MRI."}],"conflicts":[{"id":"30648265-4169-585b-b677-44a8339bb4b0","title":"Nattokinase with aspirin is reported as synergistic benefit and as a bleeding event","kind":"context_difference","status":"open","why":"A retrospective cohort by manufacturer-employed authors reports that co-administering aspirin and vitamin K2 with nattokinase improved carotid and lipid outcomes. A case report describes a cerebellar hemorrhage in a patient on aspirin with cerebral microbleeds after seven days of nattokinase. These are not the same endpoint and cannot refute each other, but they are the entire evidence base on this combination, and they point opposite ways.","resolution":"Unresolved, and unresolvable from these two designs. No formal interaction study exists.","created_at":"2026-09-23 07:55:19","record_type":"conflict","display_label":"Recorded conflict","record_url":"/conflicts/30648265-4169-585b-b677-44a8339bb4b0","sides":[{"conflict_id":"30648265-4169-585b-b677-44a8339bb4b0","ordinal":0,"label":"Aspirin with nattokinase improved the reported outcomes","revision_id":"efd063e6-e982-5f6e-a4b8-6f2ffe4185ce","start_line":1170,"end_line":1170,"quote":"Co-administration of vitamin K2 and aspirin with nattokinase produced what the authors described as a synergistic effect on the same outcomes.","source_key":"import-33bef151-bdc7-5892-aff6-0345ab149739","source_title":"Nattokinase: what the purified enzyme cleaves, what survives being eaten, and the gap between the two (2026-09-23)","claim_ids":["d182bd0f-ea42-53f0-9242-6df49e2cad6d"]},{"conflict_id":"30648265-4169-585b-b677-44a8339bb4b0","ordinal":1,"label":"Aspirin with nattokinase preceded a cerebellar hemorrhage","revision_id":"efd063e6-e982-5f6e-a4b8-6f2ffe4185ce","start_line":1390,"end_line":1390,"quote":"A patient taking aspirin for secondary stroke prevention had an acute cerebellar hemorrhage after seven consecutive days of nattokinase at 400 mg daily, with multiple cerebral microbleeds on MRI.","source_key":"import-33bef151-bdc7-5892-aff6-0345ab149739","source_title":"Nattokinase: what the purified enzyme cleaves, what survives being eaten, and the gap between the two (2026-09-23)","claim_ids":["5da84366-cafb-5ecc-ba2a-71270b48227f"]}]}],"corrections":[],"research":null}